Page 35 - 2025S
P. 35

28                                                                UEC Int’l Mini-Conference No.54







                                     Table 2: FDA Benchmark Suite Characteristics

                     Problem   Obj.   Vars.  Change Type    Key Characteristics

                     FDA 1       2     10       Type I      Convex PF, linear shift
                     FDA 2       2     10       Type II     Disconnected PF, nonlinear shift
                     FDA 3       2     10      Type III     Rotated objectives, time-dependent ge-
                                                            ometry
                     FDA 4       3     12       Type I      3D convex PF, increasing complexity
                     FDA 5       3     12       Type II     Mixed modifications, deceptive land-
                                                            scape




            4.2   Algorithm Configurations                    interval duration.

            Three algorithm configurations were evaluated
            in this study.   The conventional DNSGA-II        5    Experimental Results
            served as the baseline method for comparison.
            Two adaptive variants were bench-marked           5.1   HV Performance Comparison
            against this baseline:  (1) DNSGA-II with         The Porposed adaptive DNSGA-II performs
            decision-space  adaptation  (DNSGAII.decs),       better in all the FDA tests compared to the con-
            which utilizes solution distribution in the       ventional DNSGA-II in both decision space and
            decision space during environmental changes,      objective space.
            and (2) DNSGA-II with objective-space adap-
            tation  (DNSGAII.obj),   employing   solution     5.2   Change Response Analysis
            characteristics in the objective space when
            detecting problem dynamics.   This configura-
            tion design enables direct comparison between
            conventional and adaptive approaches while
            isolating the contributions of decision-space
            versus objective-space adaptation mechanisms

            4.3   Performance Metrics

            Four principal metrics were employed to evalu-
            ate algorithm performance. Hypervolume (HV)
            served as the primary quality indicator, cal-
            culated using a reference point of [1.2, 1.2]
            for two-objective problems. HV stability was
                                                              Figure 3: Recovery analysis after environmental
            quantified through the standard deviation met-
                         q   P                                changes in FDA 3 (τ t = 10). The hybrid ap-
                                                2
            ric σ HV =     1   T  (HV  (t)  − µ HV ) , where
                           T   t=1                            proach achieves 90% recovery in 5 generations
            µ HV represents the mean HV over T genera-
                                                              vs. 12 for standard DNSGA-II.
            tions. Recovery performance was measured via
            the recovery ratio RR (c)  = HV t c+5 /HV t c−5 at
            each change event c, capturing solution quality
            restoration within five generations post-change.  6    Discussion
            Finally, adaptation efficiency was assessed using  6.1  Adaptive Mutation Effectiveness
            the adaptation cost AC =  1  P C  t (c)  /t change ,
                                     C    c=1 90%
            which normalizes the time required to regain      The mutation adaptation mechanism effec-
            90% of pre-change HV relative to the change       tively balanced exploration-exploitation trade-
   30   31   32   33   34   35   36   37   38   39   40